Drugs targeting weight management accounted for nearly half of the increase in drug spend in 2024, and the average list price for a GLP-1 is around $1,000 per month
For patients who have not achieved adequate glycemic control with existing medications or lifestyle modifications alone, GLP-1 therapy offers a potent alternative with greater potency and longer half-life compared to some other GLP-1 RA therapies
Tuy nhin, t hiu qu ti u, bn cn ch n liu dng, ngun gc sn phm cng nh la chn ph hp vi th trng v nhu cu c nhn
This realistic vial allows learners to practice mixing medications, preparing injections, and following proper clinical procedures in a safe simulation environment without the risks associated with real sterile products
While other multi-agonists that target a variety of receptors have been explored, this specific approach has not been utilized in any previous studies
GLP-1 therapy is an investment that needs a strategy to protect it